Sang Il Kim

Mr. Sang Il Kim


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
SKSang Il Kim
Sang Il Kim
JNJinsung Noh
Jinsung Noh
SKSujeong Kim
Sujeong Kim
YCYounggeun Choi
Younggeun Choi
DYDuck-Kyun Yoo
Duck-Kyun Yoo
JCJunho Chung
Junho Chung
In six of seven severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients, V H clonotypes, encoded by either immunoglobin heavy variable (IGHV)3-53 or IGHV3-66 and immunoglobin heavy joining (IGHJ)6, were identified in IgG 1 , IgA 1 , and IgA 2 subtypes, with minimal mutations, and could be paired with diverse light chains, resulting in binding to the SARS-CoV-2 receptor-binding domain (RBD). Because most human antibodies against the RBD neutralized the virus by inhibiting host cell entry, we selected one of these clonotypes and demonstrated that it could potently inhibit viral replication. Interestingly, these V H clonotypes pre-existed in six of 10 healthy individuals, predominantly as IgM isotypes, which could explain the expeditious and stereotypic development of these clonotypes among SARS-CoV-2 patients.